Sinovac Biotech Ltd. (SVA)

6.96
0.11 1.60
NASDAQ : Health Technology
Prev Close 7.07
Open 7.02
Day Low/High 6.96 / 7.02
52 Wk Low/High 6.06 / 8.75
Volume 646.00
Avg Volume 24.40K
Exchange NASDAQ
Shares Outstanding 59.32M
Market Cap 419.40M
EPS 0.50
P/E Ratio 15.67
Div & Yield N.A. (N.A)

Latest News

Sinovac Biotech Breaks Above 200-Day Moving Average - Bullish For SVA

Sinovac Biotech Breaks Above 200-Day Moving Average - Bullish For SVA

In trading on Wednesday, shares of Sinovac Biotech Ltd crossed above their 200 day moving average of $7.71, changing hands as high as $7.74 per share. Sinovac Biotech Ltd shares are currently trading up about 1.7% on the day.

Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing A Falsified Company Seal And Forged Board Member Signatures

Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing A Falsified Company Seal And Forged Board Member Signatures

Senior management of Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company") and the lawful directors of Sinovac Hong Kong (" Lawful Directors"), Mr.

U.S. District Court In Massachusetts Denies 1Globe's Motion For Preliminary Injunction To Enjoin Sinovac's Issuance Of Shares

U.S. District Court In Massachusetts Denies 1Globe's Motion For Preliminary Injunction To Enjoin Sinovac's Issuance Of Shares

BEIJING, Oct. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd.

Sinovac Commences Legal Proceedings To Nullify Filings Bearing A Falsified Company Seal And Forged Board Member Signatures

Sinovac Commences Legal Proceedings To Nullify Filings Bearing A Falsified Company Seal And Forged Board Member Signatures

Senior management of Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company") and the lawful directors of Sinovac Hong Kong have commenced legal proceedings in the High Court of the Hong Kong Special Administrative Region to nullify and remove...

Sinovac Comments On Unauthorized Use Of Falsified Sinovac Hong Kong's Company Seal And Subsidiary Board Member Signatures

Sinovac Comments On Unauthorized Use Of Falsified Sinovac Hong Kong's Company Seal And Subsidiary Board Member Signatures

Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), became aware Monday October 8, 2018 that unauthorized changes have been made to the Hong Kong Companies Registry for Sinovac Biotech (Hong Kong) Limited ("Sinovac HK") and that unauthorized...

SVA Makes Bullish Cross Above Critical Moving Average

SVA Makes Bullish Cross Above Critical Moving Average

In trading on Friday, shares of Sinovac Biotech Ltd crossed above their 200 day moving average of $7.78, changing hands as high as $7.79 per share. Sinovac Biotech Ltd shares are currently trading down about 0.8% on the day.

DOJ Closes Investigation Of Sinovac

DOJ Closes Investigation Of Sinovac

BEIJING, Sept. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd.

SEC Concludes Investigation Of Sinovac

SEC Concludes Investigation Of Sinovac

BEIJING, Aug. 20, 2018 /PRNewswire/ -- Sinovac Biotech Ltd.

Sinovac Biotech Is Now Oversold (SVA)

Sinovac Biotech Is Now Oversold (SVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Sinovac Raises $86.73 Million Through Private Placement Transaction

Sinovac Raises $86.73 Million Through Private Placement Transaction

Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake  in Sinovac After the Private Placement Transaction Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Control and Production of New...

Sinovac Files Motion For Summary Judgment On Rights Agreement In Delaware Chancery Court

Sinovac Files Motion For Summary Judgment On Rights Agreement In Delaware Chancery Court

The summary judgment motion asks the Delaware Court to ascertain whether a trigger event under its Rights Agreement has occurred The Company recently obtained information demonstrating that the Sinobioway Consortium and the Dissident Shareholders reached...

SVA Makes Notable Cross Below Critical Moving Average

SVA Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Sinovac Biotech Ltd crossed below their 200 day moving average of $7.75, changing hands as low as $7.73 per share. Sinovac Biotech Ltd shares are currently trading down about 1.6% on the day.

Sernova's Cell Pouch Regenerative Medicine Clinical Trial For Patients With Type 1 Diabetes Supported With Continuous Glucose Monitoring Systems

Sernova's Cell Pouch Regenerative Medicine Clinical Trial For Patients With Type 1 Diabetes Supported With Continuous Glucose Monitoring Systems

Continuous Glucose Monitoring System (CGM) to provide sensitive tracking of key efficacy measures in patients at important time points throughout the study

First Week of July 2018 Options Trading For Sinovac Biotech (SVA)

First Week of July 2018 Options Trading For Sinovac Biotech (SVA)

Investors in Sinovac Biotech Ltd saw new options begin trading this week, for the July 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

September 1st Deadline Alert: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Sinovac Biotech Ltd.

September 1st Deadline Alert: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Sinovac Biotech Ltd.

Law Offices of Howard G. Smith reminds investors of the September 1, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Sinovac Biotech Ltd.

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd.

The Klein Law Firm Announces A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm Announces A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd.

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd.

SVA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

SVA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017 - SVA

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017 - SVA

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Sinovac Biotech Ltd (SVA)

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Sinovac Biotech Ltd (SVA)

The Klein Law Firm announces the commencement of an investigation of Sinovac Biotech Ltd (NASDAQ:SVA) concerning possible violations of federal securities laws.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Sinovac Biotech Ltd

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Sinovac Biotech Ltd

The Klein Law Firm announces the commencement of an investigation of Sinovac Biotech Ltd (NASDAQ: SVA) concerning possible violations of federal securities laws.

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Sinovac Biotech Ltd

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Sinovac Biotech Ltd

The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Sinovac Biotech Ltd (NASDAQ: SVA) violated federal securities laws.

SVA LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors Of Important Deadline In First Filed Class Action - SVA

SVA LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors Of Important Deadline In First Filed Class Action - SVA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sinovac Biotech Ltd.